Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Agenus, Inc. Spshot 7
Agenus, Inc. Overview 7
Key Information 7
Key Facts 7
Agenus, Inc. - Research and Development Overview 8
Key Therapeutic Areas 8
Agenus, Inc. - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Partnered Products 13
Partnered Products/Combition Treatment Modalities 14
Pipeline Products - Out-Licensed Products 15
Out-Licensed Products/Combition Treatment Modalities 16
Agenus, Inc. - Pipeline Products Glance 17
Agenus, Inc. - Clinical Stage Pipeline Products 17
Phase II Products/Combition Treatment Modalities 17
Phase I Products/Combition Treatment Modalities 18
Agenus, Inc. - Early Stage Pipeline Products 19
IND/CTA Filed Products/Combition Treatment Modalities 19
Preclinical Products/Combition Treatment Modalities 20
Agenus, Inc. - Drug Profiles 21
G-100 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
G-200 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PxM-01 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AGEN-1884 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
AGEN-2041 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclol Antibodies for Cancer 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Monoclol Antibodies for Oncology 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Monoclol Antibody for Cancer 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Monoclol Antibody to Inhibit PD-1 for Cancer 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Monoclol Antibody to Target CEACAM-1 for Oncology 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Vaccine for Oncology 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Agenus, Inc. - Pipeline Alysis 33
Agenus, Inc. - Pipeline Products by Target 33
Agenus, Inc. - Pipeline Products by Route of Administration 34
Agenus, Inc. - Pipeline Products by Molecule Type 35
Agenus, Inc. - Pipeline Products by Mechanism of Action 36
Agenus, Inc. - Recent Pipeline Updates 37
Agenus, Inc. - Dormant Projects 40
Agenus, Inc. - Discontinued Pipeline Products 41
Discontinued Pipeline Product Profiles 41
Aroplatin 41
HSPPC-70 41
Agenus, Inc. - Company Statement 42
Agenus, Inc. - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 45
Disclaimer 46